Eagle Pharmaceuticals
EGRX
#11127
Rank
NZ$5.98 M
Marketcap
NZ$0.45
Share price
0.00%
Change (1 day)
-79.41%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$5.98 Million

As of November 2026 Eagle Pharmaceuticals has a market cap of NZ$5.98 Million. This makes Eagle Pharmaceuticals the world's 11127th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.98 M-40.57%
2025NZ$10.06 M-20.33%
2024NZ$12.63 M-88.23%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.167 T 19,510,791.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$519.74 B 8,686,313.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$2.191 T 36,621,882.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$432.47 B 7,227,756.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$217.62 B 3,637,061.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$174.64 B 2,918,804.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$82.95 B 1,386,340.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel